151 related articles for article (PubMed ID: 27978591)
41. Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease.
Facey DA; Favaloro EJ; Koutts J; Berndt MC; Hertzberg MS
Br J Haematol; 1999 May; 105(2):538-41. PubMed ID: 10233434
[TBL] [Abstract][Full Text] [Related]
42. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
Graf L; Moffat KA; Carlino SA; Chan AK; Iorio A; Giulivi A; Hayward CP
Int J Lab Hematol; 2014 Jun; 36(3):341-51. PubMed ID: 24750681
[TBL] [Abstract][Full Text] [Related]
44. Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin.
Patzke J; Budde U; Huber A; Méndez A; Muth H; Obser T; Peerschke E; Wilkens M; Schneppenheim R
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):860-70. PubMed ID: 25192242
[TBL] [Abstract][Full Text] [Related]
45. Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand disease.
Chegeni R; Vickars L; Favaloro EJ; Lillicrap D; Othman M
Thromb Res; 2011 Feb; 127(2):161-6. PubMed ID: 21094983
[TBL] [Abstract][Full Text] [Related]
46. A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.
Veyradier A; Boisseau P; Fressinaud E; Caron C; Ternisien C; Giraud M; Zawadzki C; Trossaert M; Itzhar-Baïkian N; Dreyfus M; d'Oiron R; Borel-Derlon A; Susen S; Bezieau S; Denis CV; Goudemand J;
Medicine (Baltimore); 2016 Mar; 95(11):e3038. PubMed ID: 26986123
[TBL] [Abstract][Full Text] [Related]
47. Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains.
Sacco M; Lancellotti S; Ferrarese M; Bernardi F; Pinotti M; Tardugno M; De Candia E; Di Gennaro L; Basso M; Giusti B; Papi M; Perini G; Castaman G; De Cristofaro R
Blood Adv; 2020 Jul; 4(14):3405-3415. PubMed ID: 32722784
[TBL] [Abstract][Full Text] [Related]
48. A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype.
Federici AB; Mannucci PM; Stabile F; Canciani MT; Di Rocco N; Miyata S; Ware J; Ruggeri ZM
Thromb Haemost; 1997 Sep; 78(3):1132-7. PubMed ID: 9308766
[TBL] [Abstract][Full Text] [Related]
49. Laboratory diagnosis of congenital von Willebrand disease.
Budde U; Drewke E; Mainusch K; Schneppenheim R
Semin Thromb Hemost; 2002 Apr; 28(2):173-90. PubMed ID: 11992241
[TBL] [Abstract][Full Text] [Related]
50. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
Gaucher C; de Romeuf C; Rauïs-Morret M; Corazza F; Fondu P; Mazurier C
Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
[TBL] [Abstract][Full Text] [Related]
51. Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia.
Casonato A; Gallinaro L; Cattini MG; Pontara E; Padrini R; Bertomoro A; Daidone V; Pagnan A
Haematologica; 2010 Aug; 95(8):1366-72. PubMed ID: 20305138
[TBL] [Abstract][Full Text] [Related]
52. Von Willebrand disease type 2B with a novel mutation in the VWF gene.
Jeraiby MA; Sophie S; Caron C; Campos L; Brigitte T
Ann Saudi Med; 2021; 41(1):59-61. PubMed ID: 33550910
[TBL] [Abstract][Full Text] [Related]
53. 2B or not 2B? A diagnosis of von Willebrand disease a lifetime of 86 years in the making.
Chapman K; Prasad R; Mohammed S; Favaloro EJ
Blood Coagul Fibrinolysis; 2021 Apr; 32(3):229-233. PubMed ID: 33443930
[TBL] [Abstract][Full Text] [Related]
54. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor.
Inbal A; Kornbrot N; Harrison P; Randi AM; Sadler JE
Thromb Haemost; 1993 Dec; 70(6):1058-62. PubMed ID: 8165601
[TBL] [Abstract][Full Text] [Related]
55. Molecular genetics of von Willebrand disease.
Mazurier C; Ribba AS; Gaucher C; Meyer D
Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
[TBL] [Abstract][Full Text] [Related]
56. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
[TBL] [Abstract][Full Text] [Related]
57. Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma.
Takimoto Y; Imanaka F
Int J Hematol; 1999 Aug; 70(2):127-31. PubMed ID: 10497852
[TBL] [Abstract][Full Text] [Related]
58. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
59. [Gene mutation analysis of one case with von willebrand disease type 2A].
Hou LH; Zhang Y; Liu XE; Yang LH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1040-2. PubMed ID: 19698255
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis and management of adult patients with von Willebrand disease in South Australia.
Rodgers SE; Lloyd JV; Mangos HM; Duncan EM; McRae SJ
Semin Thromb Hemost; 2011 Jul; 37(5):535-41. PubMed ID: 22102197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
